Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPP-ACP Pastes for White Spot Lesion Progression
NCT03656432Phase 3Unknown
- Sponsor
- Cairo University
- Start
- Oct 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of casein phosphopeptide-amorphous calcium phosphate in dental caries (3 arms), sponsored by Cairo University. Primary endpoint: White Spot Lesion progression at 1 month. Status: unknown.
02
Drugs
casein phosphopeptide-amorphous calcium phosphate
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT03656432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03656432.